COCRYSTAL PHARMA NEW O.N. Financial Flexibility Index
COCRYSTAL PHARMA NEW O.N. financial flexibility index. COCRYSTAL PHARMA NEW O.N. (8CC) has a Financial Flexibility Index of -0.51x as of December 2025. Free cash flow of €-1.74 Million (operating CF €-1.74 Million minus capex €0.00) represents -1% of total liabilities (€3.38 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of COCRYSTAL PHARMA NEW O.N. (2021–2025)
Financial flexibility index of COCRYSTAL PHARMA NEW O.N. from 2021 to 2025. Historical Financial Flexibility Index trend for COCRYSTAL PHARMA NEW O.N. across 5 annual periods. Explore cash flow to debt ratio of COCRYSTAL PHARMA NEW O.N. to assess how comfortably operating cash covers total debt obligations.
COCRYSTAL PHARMA NEW O.N. Financial Flexibility Index by Year (2021–2025)
COCRYSTAL PHARMA NEW O.N. financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for COCRYSTAL PHARMA NEW O.N.. For the full cash flow conversion analysis, see 8CC cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.42x | €-8.18 Million | €-8.19 Million | €3.38 Million | ▲ +42.2% |
| 2024 | -4.19x | €-16.48 Million | €-16.48 Million | €3.93 Million | ▼ -40.4% |
| 2023 | -2.98x | €-14.55 Million | €-14.67 Million | €4.88 Million | ▲ +82.2% |
| 2022 | -16.78x | €-21.36 Million | €-21.43 Million | €1.27 Million | ▼ -144.1% |
| 2021 | -6.87x | €-12.67 Million | €-12.72 Million | €1.84 Million | — |